KRAS and lung cancer: A combination of the TRAIL and Smac mimic (allows overcoming KRAS-induced survival in cancer cells) was shown to induce strong apoptosis in premalignant lung adenoma cells and inhibit the formation of KRAS-induced lung cancer in vivo [76].